Prenatal Screening Webinars
Improved pre-eclampsia management with sFlt-1/PlGF ratio
Join us to learn from health care professionals who already introduced sFlt-1/PlGF in their clinical routine
Thursday, October 7th, 2021, CEST (Berlin) 11.00–12.30. Duration: 1 hour, 30 minutes
Also available on demand after October 7th
The live webinar is dedicated to the topic of improved diagnosis and prognosis of pre-eclampsia with the aid of sFlt-1/PlGF biomarker ratio. Join us to learn from health care professionals who already introduced sFlt-1/PlGF in their clinical routine. You will have an opportunity to address your questions to the clinical practitioners, exchange your ideas and learn about use of sFlt-1/PlGF on examples of clinical cases.
A Certificate of Attendance will be sent to participants.
- Implementation of sFlt-1/PlGF ratio in clinical routine: A retrospective study
Martin Overgaard, Denmark
- Evaluation of the prognostic value of the sFlt-1/PlGF ratio in early-onset pre-eclampsia
Paul Guerby, France
- The aid of sFlt-1/PlGF ratio in pre-eclampsia patient management on examples of clinical cases
Ignacio Herraiz, Spain
- Clinical value of pre-eclampsia biomarkers in high-risk pregnancies: Case reports
Roman Kapustin, Russia
- Live Q&A
Let’s stay connected!
Continue receiving Thermo Fisher Scientific emails and content by clicking the "Subscribe now!" button below.